{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:14:59Z","timestamp":1792721699765,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24772-4","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:36:33Z","timestamp":1763634993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Restoring apoptosis in breast cancer via peptide mediated disruption of survivin IAP interaction"],"prefix":"10.1038","volume":"15","author":[{"given":"Seyedeh Marzieh","family":"Taghavifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Sabbaghfarshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Samadikhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Hesami","family":"Tackallou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Fatemeh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"6","key":"24772_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s12276-025-01470-9","volume":"57","author":"SH Dho","year":"2025","unstructured":"Dho, S. H., Cho, M., Woo, W., Jeong, S. & Kim, L. K. Caspases as master regulators of programmed cell death: Apoptosis, pyroptosis and beyond. Exp. Mol. Med. 57(6), 1121\u20131132. https:\/\/doi.org\/10.1038\/s12276-025-01470-9 (2025).","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"24772_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 35(4), 495\u2013516. https:\/\/doi.org\/10.1080\/01926230701320337 (2007).","journal-title":"Toxicol. Pathol."},{"issue":"9","key":"24772_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1096\/fba.2024-00067","volume":"6","author":"X Li","year":"2024","unstructured":"Li, X. et al. G protein coupled receptor in apoptosis and apoptotic cell clearance. FASEB Bioadv. 6(9), 289\u2013297. https:\/\/doi.org\/10.1096\/fba.2024-00067 (2024).","journal-title":"FASEB Bioadv."},{"issue":"3","key":"24772_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41416-022-02020-0","volume":"128","author":"C N\u00f6ssing","year":"2023","unstructured":"N\u00f6ssing, C. & Ryan, K. M. 50 years on and still very much alive: \u2018Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics\u2019. Br. J. Cancer 128(3), 426\u2013431. https:\/\/doi.org\/10.1038\/s41416-022-02020-0 (2023).","journal-title":"Br. J. Cancer"},{"issue":"8","key":"24772_CR5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s12276-023-01078-x","volume":"55","author":"W Park","year":"2023","unstructured":"Park, W. et al. Diversity and complexity of cell death: a historical review. Exp. Mol. Med. 55(8), 1573\u20131594. https:\/\/doi.org\/10.1038\/s12276-023-01078-x (2023).","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"24772_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12541","volume":"277","author":"B Tummers","year":"2017","unstructured":"Tummers, B. & Green, D. R. Caspase-8: regulating life and death. Immunol Rev 277(1), 76\u201389. https:\/\/doi.org\/10.1111\/imr.12541 (2017).","journal-title":"Immunol Rev"},{"issue":"2","key":"24772_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrd3627","volume":"11","author":"S Fulda","year":"2012","unstructured":"Fulda, S. & Vucic, D. Targeting IAP proteins for therapeutic intervention in cancer. Nat. Rev. Drug Discov. 11(2), 109\u2013124. https:\/\/doi.org\/10.1038\/nrd3627 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"24772_CR8","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/biomedicines13071745","volume":"13","author":"P-C Hsu","year":"2025","unstructured":"Hsu, P.-C., Tsai, C.-C., Lin, Y.-H. & Kuo, C.-Y. Therapeutic targeting of apoptosis, autophagic cell death, necroptosis, pyroptosis, and ferroptosis pathways in oral squamous cell carcinoma: molecular mechanisms and potential strategies. Biomedicines 13(7), 1745 (2025).","journal-title":"Biomedicines"},{"key":"24772_CR9","doi-asserted-by":"publisher","first-page":"107610","DOI":"10.1016\/j.pharmthera.2020.107610","volume":"214","author":"S Kumar","year":"2020","unstructured":"Kumar, S., Fairmichael, C., Longley, D. B. & Turkington, R. C. The Multiple Roles of the IAP Super-family in cancer. Pharmacol. Therap. 214, 107610. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107610 (2020).","journal-title":"Pharmacol. Therap."},{"key":"24772_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008730","author":"J Silke","year":"2013","unstructured":"Silke, J. & Meier, P. Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a008730 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"24772_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1562167","author":"Q Ye","year":"2025","unstructured":"Ye, Q., Zhuang, X.-Z., Li, J. & Zhou, X. Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers [Review]. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1562167 (2025).","journal-title":"Front. Pharmacol."},{"key":"24772_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071671","author":"P Cetraro","year":"2022","unstructured":"Cetraro, P., Plaza-Diaz, J., MacKenzie, A. & Abad\u00eda-Molina, F. A review of the current impact of inhibitors of apoptosis proteins and their repression in cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14071671 (2022).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"24772_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12929-020-0627-5","volume":"27","author":"CHA Cheung","year":"2020","unstructured":"Cheung, C. H. A., Chang, Y. C., Lin, T. Y., Cheng, S. M. & Leung, E. Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE. J. Biomed. Sci. 27(1), 31. https:\/\/doi.org\/10.1186\/s12929-020-0627-5 (2020).","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"24772_CR14","first-page":"200","volume":"34","author":"MC de Almagro","year":"2012","unstructured":"de Almagro, M. C. & Vucic, D. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Exp Oncol 34(3), 200\u2013211 (2012).","journal-title":"Exp Oncol"},{"issue":"1","key":"24772_CR15","doi-asserted-by":"publisher","first-page":"21710","DOI":"10.1038\/srep21710","volume":"6","author":"D Wang","year":"2016","unstructured":"Wang, D. et al. BIRC3 is a novel driver of therapeutic resistance in Glioblastoma. Sci. Rep. 6(1), 21710. https:\/\/doi.org\/10.1038\/srep21710 (2016).","journal-title":"Sci. Rep."},{"key":"24772_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107463","author":"B Gao","year":"2024","unstructured":"Gao, B. et al. USP36 inhibits apoptosis by deubiquitinating cIAP1 and survivin in colorectal cancer cells. J. Biol. Chem. https:\/\/doi.org\/10.1016\/j.jbc.2024.107463 (2024).","journal-title":"J. Biol. Chem."},{"key":"24772_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.886537","volume":"10","author":"MP Schwalm","year":"2022","unstructured":"Schwalm, M. P. et al. A toolbox for the generation of chemical probes for baculovirus IAP repeat containing proteins. Front. Cell Dev. Biol. 10, 886537. https:\/\/doi.org\/10.3389\/fcell.2022.886537 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"24772_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020322","author":"A Zadoroznyj","year":"2022","unstructured":"Zadoroznyj, A. & Dubrez, L. Cytoplasmic and nuclear functions of cIAP1. Biomolecules https:\/\/doi.org\/10.3390\/biom12020322 (2022).","journal-title":"Biomolecules"},{"issue":"9","key":"24772_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022356","volume":"6","author":"MJ Bertrand","year":"2011","unstructured":"Bertrand, M. J. et al. cIAP1\/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1\u20134 (RIP1-4). PLoS ONE 6(9), e22356. https:\/\/doi.org\/10.1371\/journal.pone.0022356 (2011).","journal-title":"PLoS ONE"},{"issue":"1","key":"24772_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/app11010335","volume":"11","author":"Y-C Chang","year":"2021","unstructured":"Chang, Y.-C. & Cheung, C. H. A. An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment. Appl. Sci. 11(1), 335 (2021).","journal-title":"Appl. Sci."},{"issue":"1","key":"24772_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cdd.2011.163","volume":"19","author":"M Darding","year":"2012","unstructured":"Darding, M. & Meier, P. IAPs: Guardians of RIPK1. Cell Death Differ. 19(1), 58\u201366. https:\/\/doi.org\/10.1038\/cdd.2011.163 (2012).","journal-title":"Cell Death Differ."},{"issue":"10","key":"24772_CR22","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1021\/ar8000553","volume":"41","author":"H Sun","year":"2008","unstructured":"Sun, H. et al. Design of small-molecule peptidic and nonpeptidic Smac mimetics. Acc. Chem. Res. 41(10), 1264\u20131277. https:\/\/doi.org\/10.1021\/ar8000553 (2008).","journal-title":"Acc. Chem. Res."},{"issue":"12","key":"24772_CR23","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/cdd.2008.124","volume":"15","author":"M Sun","year":"2008","unstructured":"Sun, M., Song, L., Li, Y., Zhou, T. & Jope, R. S. Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ. 15(12), 1887\u20131900. https:\/\/doi.org\/10.1038\/cdd.2008.124 (2008).","journal-title":"Cell Death Differ."},{"issue":"7","key":"24772_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.4049\/jimmunol.2200646","volume":"210","author":"KS Ventre","year":"2023","unstructured":"Ventre, K. S. et al. cIAP1\/2 Antagonism induces antigen-specific T cell-dependent immunity. J Immunol 210(7), 991\u20131003. https:\/\/doi.org\/10.4049\/jimmunol.2200646 (2023).","journal-title":"J Immunol"},{"issue":"6","key":"24772_CR25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.biocel.2010.02.008","volume":"42","author":"J Davoodi","year":"2010","unstructured":"Davoodi, J., Ghahremani, M. H., Es-Haghi, A., Mohammad-Gholi, A. & Mackenzie, A. Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9. Int. J. Biochem. Cell Biol. 42(6), 958\u2013964. https:\/\/doi.org\/10.1016\/j.biocel.2010.02.008 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"39","key":"24772_CR26","doi-asserted-by":"publisher","first-page":"40622","DOI":"10.1074\/jbc.M405963200","volume":"279","author":"J Davoodi","year":"2004","unstructured":"Davoodi, J., Lin, L., Kelly, J., Liston, P. & MacKenzie, A. E. Neuronal apoptosis-inhibitory protein does not interact with Smac and requires ATP to bind caspase-9 *. J. Biol. Chem. 279(39), 40622\u201340628. https:\/\/doi.org\/10.1074\/jbc.M405963200 (2004).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"24772_CR27","doi-asserted-by":"publisher","first-page":"39981","DOI":"10.1038\/srep39981","volume":"7","author":"F Abad\u00eda-Molina","year":"2017","unstructured":"Abad\u00eda-Molina, F. et al. Neuronal apoptosis inhibitory protein (NAIP) localizes to the cytokinetic machinery during cell division. Sci. Rep. 7(1), 39981. https:\/\/doi.org\/10.1038\/srep39981 (2017).","journal-title":"Sci. Rep."},{"issue":"Suppl","key":"24772_CR28","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3346\/jkms.2007.22.S.S17","volume":"22","author":"J Choi","year":"2007","unstructured":"Choi, J. et al. Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer. J. Korean Med. Sci. 22(Suppl), S17\u2013S23. https:\/\/doi.org\/10.3346\/jkms.2007.22.S.S17 (2007).","journal-title":"J. Korean Med. Sci."},{"issue":"6","key":"24772_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286647","volume":"18","author":"W-B Xu","year":"2023","unstructured":"Xu, W.-B. et al. Pan-cancer analysis of the intervertebral-disc-degeneration-related innate immunity gene NAIP. PLoS ONE 18(6), e0286647. https:\/\/doi.org\/10.1371\/journal.pone.0286647 (2023).","journal-title":"PLoS ONE"},{"issue":"2","key":"24772_CR30","first-page":"683","volume":"9","author":"L Yang","year":"2017","unstructured":"Yang, L., Zhao, W., Wei, P., Zuo, W. & Zhu, S. Tumor suppressor p53 induces miR-15a processing to inhibit neuronal apoptosis inhibitory protein (NAIP) in the apoptotic response DNA damage in breast cancer cell. Am. J. Transl. Res. 9(2), 683\u2013691 (2017).","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"24772_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s10142-025-01615-z","volume":"25","author":"AM Ayoub","year":"2025","unstructured":"Ayoub, A. M. et al. BIRC5 as a master regulator in HCC: Unraveling its role in tumor survival and therapeutic potential. Funct. Integr. Genomics 25(1), 120. https:\/\/doi.org\/10.1007\/s10142-025-01615-z (2025).","journal-title":"Funct. Integr. Genomics"},{"issue":"3","key":"24772_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/1061186x.2024.2309563","volume":"32","author":"XL Fang","year":"2024","unstructured":"Fang, X. L. et al. Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target. J. Drug Target 32(3), 223\u2013240. https:\/\/doi.org\/10.1080\/1061186x.2024.2309563 (2024).","journal-title":"J. Drug Target"},{"key":"24772_CR33","doi-asserted-by":"publisher","first-page":"122260","DOI":"10.1016\/j.lfs.2023.122260","volume":"335","author":"SK Kondapuram","year":"2023","unstructured":"Kondapuram, S. K., Ramachandran, H. K., Arya, H. & Coumar, M. S. Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development. Life Sci. 335, 122260. https:\/\/doi.org\/10.1016\/j.lfs.2023.122260 (2023).","journal-title":"Life Sci."},{"issue":"9","key":"24772_CR34","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3390\/cancers16091705","volume":"16","author":"Q Wang","year":"2024","unstructured":"Wang, Q. & Greene, M. I. Survivin as a therapeutic target for the treatment of human cancer. Cancers 16(9), 1705 (2024).","journal-title":"Cancers"},{"key":"24772_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","volume":"16","author":"H Garg","year":"2016","unstructured":"Garg, H., Suri, P., Gupta, J. C., Talwar, G. P. & Dubey, S. Survivin: a unique target for tumor therapy. Cancer Cell Int. 16, 49. https:\/\/doi.org\/10.1186\/s12935-016-0326-1 (2016).","journal-title":"Cancer Cell Int."},{"issue":"1","key":"24772_CR36","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41467-021-21753-9","volume":"12","author":"A Meiners","year":"2021","unstructured":"Meiners, A. et al. Specific inhibition of the Survivin\u2013CRM1 interaction by peptide-modified molecular tweezers. Nat. Commun. 12(1), 1505. https:\/\/doi.org\/10.1038\/s41467-021-21753-9 (2021).","journal-title":"Nat. Commun."},{"issue":"4","key":"24772_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/cej.0000000000000453","volume":"28","author":"F Shojaei","year":"2019","unstructured":"Shojaei, F., Yazdani-Nafchi, F., Banitalebi-Dehkordi, M., Chehelgerdi, M. & Khorramian-Ghahfarokhi, M. Trace of survivin in cancer. Eur. J. Cancer Prev. 28(4), 365\u2013372. https:\/\/doi.org\/10.1097\/cej.0000000000000453 (2019).","journal-title":"Eur. J. Cancer Prev."},{"issue":"6","key":"24772_CR38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1590\/1806-9282.65.6.893","volume":"65","author":"GLD Veiga","year":"2019","unstructured":"Veiga, G. L. D. et al. The role of Survivin as a biomarker and potential prognostic factor for breast cancer. Rev. Assoc. Med. Bras. 65(6), 893\u2013901. https:\/\/doi.org\/10.1590\/1806-9282.65.6.893 (2019).","journal-title":"Rev. Assoc. Med. Bras."},{"issue":"12","key":"24772_CR39","doi-asserted-by":"publisher","first-page":"21575","DOI":"10.1002\/jcp.28784","volume":"234","author":"P Zafari","year":"2019","unstructured":"Zafari, P., Rafiei, A., Esmaeili, S. A., Moonesi, M. & Taghadosi, M. Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. J. Cell Physiol. 234(12), 21575\u201321587. https:\/\/doi.org\/10.1002\/jcp.28784 (2019).","journal-title":"J. Cell Physiol."},{"key":"24772_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/or.2024.1444008","author":"AH Chuwa","year":"2024","unstructured":"Chuwa, A. H. & Mvunta, D. H. Prognostic and clinicopathological significance of survivin in gynecological cancer. Oncol. Rev. https:\/\/doi.org\/10.3389\/or.2024.1444008 (2024).","journal-title":"Oncol. Rev."},{"issue":"9379","key":"24772_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0140-6736(03)13910-4","volume":"362","author":"PJ Kim","year":"2003","unstructured":"Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R. & Altieri, D. C. Survivin and molecular pathogenesis of colorectal cancer. Lancet 362(9379), 205\u2013209. https:\/\/doi.org\/10.1016\/s0140-6736(03)13910-4 (2003).","journal-title":"Lancet"},{"key":"24772_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091705","author":"Q Wang","year":"2024","unstructured":"Wang, Q. & Greene, M. I. Survivin as a therapeutic target for the treatment of human cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers16091705 (2024).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"24772_CR43","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/molecules28031376","volume":"28","author":"N Albadari","year":"2023","unstructured":"Albadari, N. & Li, W. Survivin small molecules inhibitors: recent advances and challenges. Molecules 28(3), 1376 (2023).","journal-title":"Molecules"},{"issue":"12","key":"24772_CR44","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrm3474","volume":"13","author":"M Carmena","year":"2012","unstructured":"Carmena, M., Wheelock, M., Funabiki, H. & Earnshaw, W. C. The chromosomal passenger complex (CPC): From easy rider to the godfather of mitosis. Nat. Rev. Mol. Cell Biol. 13(12), 789\u2013803. https:\/\/doi.org\/10.1038\/nrm3474 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"24772_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13046-020-01581-3","volume":"39","author":"W Fang","year":"2020","unstructured":"Fang, W. et al. Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex. J. Exp. Clin. Cancer Res. 39(1), 82. https:\/\/doi.org\/10.1186\/s13046-020-01581-3 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"24772_CR46","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1021\/acs.bioconjchem.2c00398","volume":"33","author":"I Nozaki","year":"2022","unstructured":"Nozaki, I. et al. Borealin-derived peptides as survivin-targeting cancer imaging and therapeutic agents. Bioconjug. Chem. 33(11), 2149\u20132160. https:\/\/doi.org\/10.1021\/acs.bioconjchem.2c00398 (2022).","journal-title":"Bioconjug. Chem."},{"key":"24772_CR47","doi-asserted-by":"publisher","unstructured":"Wheatley, S. P., & McNeish, I. A. Survivin: A Protein with dual roles in mitosis and apoptosis. In International Review of Cytology 35\u201388, Vol. 247. (Academic Press, 2005). https:\/\/doi.org\/10.1016\/S0074-7696(05)47002-3","DOI":"10.1016\/S0074-7696(05)47002-3"},{"issue":"1","key":"24772_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2014.05.007","volume":"144","author":"L Bai","year":"2014","unstructured":"Bai, L., Smith, D. C. & Wang, S. Small-molecule SMAC mimetics as new cancer therapeutics. Pharmacol. Ther. 144(1), 82\u201395. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.05.007 (2014).","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"24772_CR49","doi-asserted-by":"publisher","first-page":"11383","DOI":"10.1038\/s41598-017-11426-3","volume":"7","author":"TA Werner","year":"2017","unstructured":"Werner, T. A. et al. Survivin and XIAP \u2013 two potential biological targets in follicular thyroid carcinoma. Sci. Rep. 7(1), 11383. https:\/\/doi.org\/10.1038\/s41598-017-11426-3 (2017).","journal-title":"Sci. Rep."},{"issue":"26","key":"24772_CR50","doi-asserted-by":"publisher","first-page":"23296","DOI":"10.1074\/jbc.M111.237586","volume":"286","author":"MS Pavlyukov","year":"2011","unstructured":"Pavlyukov, M. S. et al. Survivin monomer plays an essential role in apoptosis regulation. J. Biol. Chem. 286(26), 23296\u201323307. https:\/\/doi.org\/10.1074\/jbc.M111.237586 (2011).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"24772_CR51","doi-asserted-by":"publisher","first-page":"30599","DOI":"10.1038\/s41598-025-13110-3","volume":"15","author":"SF Ahmadi","year":"2025","unstructured":"Ahmadi, S. F., Arab, S. S. & Samadikhah, H. Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer. Sci. Rep. 15(1), 30599. https:\/\/doi.org\/10.1038\/s41598-025-13110-3 (2025).","journal-title":"Sci. Rep."},{"key":"24772_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41401-022-00939-x","volume":"44","author":"H Yin","year":"2023","unstructured":"Yin, H. et al. The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus. Acta Pharmacol. Sin. 44, 201 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"24772_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106674","volume":"138","author":"H Yin","year":"2023","unstructured":"Yin, H. et al. Design, synthesis and anticancer evaluation of novel oncolytic peptide-chlorambucil conjugates. Bioorg. Chem. 138, 106674 (2023).","journal-title":"Bioorg. Chem."},{"issue":"10","key":"24772_CR54","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41419-021-04240-3","volume":"12","author":"S Dhani","year":"2021","unstructured":"Dhani, S., Zhao, Y. & Zhivotovsky, B. A long way to go: caspase inhibitors in clinical use. Cell Death Dis. 12(10), 949. https:\/\/doi.org\/10.1038\/s41419-021-04240-3 (2021).","journal-title":"Cell Death Dis."},{"issue":"1","key":"24772_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40259-013-0058-x","volume":"28","author":"B Groner","year":"2014","unstructured":"Groner, B. & Weiss, A. Targeting survivin in cancer: novel drug development approaches. BioDrugs 28(1), 27\u201339. https:\/\/doi.org\/10.1007\/s40259-013-0058-x (2014).","journal-title":"BioDrugs"},{"key":"24772_CR56","unstructured":"Survivin-Targeted anticancer vaccine undergoes investigation in metastatic neuroendocrine neoplasms. Oncology Live\u00ae, 24. https:\/\/www.onclive.com\/view\/survivin-targeted-anticancer-vaccine-undergoes-investigation-in-metastatic-neuroendocrine-neoplasms Vol. 24\/No. 4, 2023."},{"issue":"5","key":"24772_CR57","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1021\/acs.jmedchem.3c02232","volume":"67","author":"X-Y Fu","year":"2024","unstructured":"Fu, X.-Y. et al. Three rounds of stability-guided optimization and systematical evaluation of oncolytic peptide LTX-315. J. Med. Chem. 67(5), 3885\u20133908. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c02232 (2024).","journal-title":"J. Med. Chem."},{"issue":"35","key":"24772_CR58","doi-asserted-by":"publisher","first-page":"14506","DOI":"10.1039\/D4SC04825C","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu, H., Chow, H. Y., Liu, J., Shi, P. & Li, X. Prior disulfide bond-mediated Ser\/Thr ligation. Chem. Sci. 15(35), 14506\u201314512. https:\/\/doi.org\/10.1039\/D4SC04825C (2024).","journal-title":"Chem. Sci."},{"issue":"1","key":"24772_CR59","doi-asserted-by":"publisher","first-page":"2110218","DOI":"10.1080\/2162402x.2022.2110218","volume":"11","author":"A Mougel","year":"2022","unstructured":"Mougel, A. et al. Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling. Oncoimmunology 11(1), 2110218. https:\/\/doi.org\/10.1080\/2162402x.2022.2110218 (2022).","journal-title":"Oncoimmunology"},{"key":"24772_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28207165","author":"G Rossino","year":"2023","unstructured":"Rossino, G. et al. Peptides as therapeutic agents: challenges and opportunities in the green transition era. Molecules https:\/\/doi.org\/10.3390\/molecules28207165 (2023).","journal-title":"Molecules"},{"issue":"6","key":"24772_CR61","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","volume":"55","author":"SMP Vadevoo","year":"2023","unstructured":"Vadevoo, S. M. P. et al. Peptides as multifunctional players in cancer therapy. Exp. Mol. Med. 55(6), 1099\u20131109. https:\/\/doi.org\/10.1038\/s12276-023-01016-x (2023).","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"24772_CR62","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/mabi.201300046","volume":"13","author":"DJ Gary","year":"2013","unstructured":"Gary, D. J., Min, J., Kim, Y., Park, K. & Won, Y. Y. The effect of N\/P ratio on the in vitro and in vivo interaction properties of PEGylated poly[2-(dimethylamino)ethyl methacrylate]-based siRNA complexes. Macromol. Biosci. 13(8), 1059\u20131071. https:\/\/doi.org\/10.1002\/mabi.201300046 (2013).","journal-title":"Macromol. Biosci."},{"issue":"1","key":"24772_CR63","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/21691401.2023.2247036","volume":"51","author":"S Pande","year":"2023","unstructured":"Pande, S. Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artif. Cells Nanomed. Biotechnol. 51(1), 428\u2013440. https:\/\/doi.org\/10.1080\/21691401.2023.2247036 (2023).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"24772_CR64","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2147\/ijn.S23074","volume":"6","author":"HR Samadikhah","year":"2011","unstructured":"Samadikhah, H. R., Majidi, A., Nikkhah, M. & Hosseinkhani, S. Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes. Int. J. Nanomed. 6, 2275\u20132283. https:\/\/doi.org\/10.2147\/ijn.S23074 (2011).","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"24772_CR65","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19(6), 679\u2013682. https:\/\/doi.org\/10.1038\/s41592-022-01488-1 (2022).","journal-title":"Nat. Methods"},{"key":"24772_CR66","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-7231-9_4","volume":"1654","author":"B Webb","year":"2017","unstructured":"Webb, B. & Sali, A. Protein Structure Modeling with MODELLER. Methods Mol. Biol. 1654, 39\u201354. https:\/\/doi.org\/10.1007\/978-1-4939-7231-9_4 (2017).","journal-title":"Methods Mol. Biol."},{"key":"24772_CR67","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-0716-0708-4_9","volume":"2165","author":"A Alekseenko","year":"2020","unstructured":"Alekseenko, A., Ignatov, M., Jones, G., Sabitova, M. & Kozakov, D. Protein-protein and protein-peptide docking with ClusPro server. Methods Mol. Biol. 2165, 157\u2013174. https:\/\/doi.org\/10.1007\/978-1-0716-0708-4_9 (2020).","journal-title":"Methods Mol. Biol."},{"issue":"Pt 6","key":"24772_CR68","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1107\/s2059798322002741","volume":"78","author":"G Jones","year":"2022","unstructured":"Jones, G. et al. Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap. Acta Crystallogr. D Struct. Biol. 78(Pt 6), 690\u2013697. https:\/\/doi.org\/10.1107\/s2059798322002741 (2022).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"issue":"10","key":"24772_CR69","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51(10), 2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u (2011).","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"24772_CR70","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth, S. A. & Dror, R. O. Molecular dynamics simulation for all. Neuron 99(6), 1129\u20131143. https:\/\/doi.org\/10.1016\/j.neuron.2018.08.011 (2018).","journal-title":"Neuron"},{"key":"24772_CR71","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.1c00645","author":"M Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M., Vald\u00e9s-Tresanco, M., Valiente, P. & Moreno Frias, E. gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Computat. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645 (2021).","journal-title":"J. Chem. Theory Computat."},{"issue":"1","key":"24772_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12645-024-00271-5","volume":"15","author":"N Mahdizadeh","year":"2024","unstructured":"Mahdizadeh, N., Khorshid Shabestari, M., Tafvizi, F. & Khodarahmi, P. Delivery of letrozole-encapsulated niosomes via a 3D bioprinting gelatin\u2013alginate scaffold for potential breast cancer treatment. Cancer Nanotechnol. 15(1), 33. https:\/\/doi.org\/10.1186\/s12645-024-00271-5 (2024).","journal-title":"Cancer Nanotechnol."},{"key":"24772_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008145","author":"J Qian","year":"2024","unstructured":"Qian, J. et al. Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2023-008145 (2024).","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"24772_CR74","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1038\/cddis.2011.8","volume":"2","author":"A M\u00fchlethaler-Mottet","year":"2011","unstructured":"M\u00fchlethaler-Mottet, A. et al. Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis. Cell Death Dis. 2(3), e125\u2013e125. https:\/\/doi.org\/10.1038\/cddis.2011.8 (2011).","journal-title":"Cell Death Dis."},{"issue":"1","key":"24772_CR75","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1038\/s41598-025-89714-6","volume":"15","author":"RA Parry","year":"2025","unstructured":"Parry, R. A. et al. Exploring the cytotoxic effects of bioactive compounds from Alcea rosea against stem cell driven colon carcinogenesis. Sci. Rep. 15(1), 5892. https:\/\/doi.org\/10.1038\/s41598-025-89714-6 (2025).","journal-title":"Sci. Rep."},{"key":"24772_CR76","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7439.1000316","author":"CM Figueroa","year":"2015","unstructured":"Figueroa, C. M. et al. Induction of cancer cell death by hyaluronic acid-mediated uptake of cytochrome C. J. Nanomed. Nanotechnol. https:\/\/doi.org\/10.4172\/2157-7439.1000316 (2015).","journal-title":"J. Nanomed. Nanotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24772-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:36:34Z","timestamp":1763634994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24772-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24772"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24772-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40947"}}